WA
SILK

Wasatch Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Wasatch Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-262,654
Closed -$7.1M – 253
2024
Q2 		$7.1M Sell
262,654
-4,287,088
-94% -$89.2M 0.04% 177
2024
Q1 		$83.4M Buy
4,549,742
+500,581
+12% +$7.94M 0.44% 70
2023
Q4 		$49.7M Sell
4,049,161
-1,658,512
-29% -$15.6M 0.27% 85
2023
Q3 		$85.6M Buy
5,707,673
+460,712
+9% +$9.59M 0.54% 57
2023
Q2 		$170M Buy
5,246,961
+2,002,423
+62% +$73.1M 1.03% 35
2023
Q1 		$127M Buy
3,244,538
+181,397
+6% +$8.87M 0.79% 43
2022
Q4 		$162M Sell
3,063,141
-433,616
-12% -$21.1M 1.09% 29
2022
Q3 		$157M Sell
3,496,757
-444,422
-11% -$19.1M 1.09% 27
2022
Q2 		$143M Sell
3,941,179
-146,650
-4% -$5.33M 0.91% 34
2022
Q1 		$169M Buy
4,087,829
+306,577
+8% +$10.8M 0.83% 41
2021
Q4 		$161M Buy
3,781,252
+449,414
+13% +$22.5M 0.66% 50
2021
Q3 		$183M Buy
3,331,838
+407,090
+14% +$21.3M 0.75% 43
2021
Q2 		$140M Buy
2,924,748
+17,301
+0.6% +$882K 0.57% 63
2021
Q1 		$147M Buy
2,907,447
+277,434
+11% +$15.4M 0.66% 55
2020
Q4 		$166M Buy
2,630,013
+39,500
+2% +$2.45M 0.82% 42
2020
Q3 		$174M Buy
2,590,513
+59,914
+2% +$3.27M 1.11% 29
2020
Q2 		$106M Buy
2,530,599
+1,088,358
+75% +$41.8M 0.77% 46
2020
Q1 		$45.4M Buy
1,442,241
+1,000,885
+227% +$40.1M 0.47% 67
2019
Q4 		$17.8M Buy
441,356
+405,656
+1,136% +$14.2M 0.15% 119
2019
Q3 		$1.16M Buy
+35,700
New +$1.42M 0.01% 234

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wasatch Advisors's SILK Position: Q3 2024 in Review

Wasatch Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 262,654 shares — an estimated $7.1M sold.

Wasatch Advisors first reported a position in SILK in Q3 2019 and held it in 20 quarters. The position peaked at $183M in Q3 2021. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Wasatch Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Wasatch Advisors sold 262,654 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $7.1M.
  • Wasatch Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 20 quarters.
  • Wasatch Advisors's Silk Road Medical, Inc. Common Stock position peaked at $183M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Wasatch Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.